drugset / Trial / NCT00022334
Vaccine Therapy in Treating Patients With Liver Cancer
Phase 1/2
Completed
33 enrolled
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor proteins may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have liver cancer.
Timeline
- Start
- 2001-01
- Primary completion
- 2004-12
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AFP peptide-pulsed autologous DC | Unknown | — | Other |